Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia - Archive ouverte HAL Access content directly
Journal Articles BMC Biology Year : 2019

Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia

(1) , (1) , (1)
1

Abstract

Changes in cell metabolism and metabolic adaptation are hallmark features of many cancers, including leukemia, that support biological processes involved into tumor initiation, growth, and response to therapeutics. The discovery of mutations in key metabolic enzymes has highlighted the importance of metabolism in cancer biology and how these changes might constitute an Achilles heel for cancer treatment. In this Review, we discuss the role of metabolic and mitochondrial pathways dysregulated in acute myeloid leukemia, and the potential of therapeutic intervention targeting these metabolic dependencies on the proliferation, differentiation, stem cell function and cell survival to improve patient stratification and outcomes.
Fichier principal
Vignette du fichier
s12915-019-0670-4.pdf (1.18 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

inserm-02441720 , version 1 (16-01-2020)

Identifiers

Cite

Lucille Stuani, Marie Sabatier, Jean-Emmanuel Sarry. Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia. BMC Biology, 2019, 17 (1), pp.57. ⟨10.1186/s12915-019-0670-4⟩. ⟨inserm-02441720⟩
51 View
123 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More